We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Still Not in Gear on Quality; FDA Considering QbD Incentives, Woodcock Says
Drugmakers Still Not in Gear on Quality; FDA Considering QbD Incentives, Woodcock Says
June 4, 2012
BALTIMORE — Despite recurring pharma quality problems, drugmakers are still inclined to meet minimum manufacturing standards set by regulators, rather than make quality central to their business model.